4.5 Article

P-glycoprotein down-regulates expression of breast cancer resistance protein in a drug-free state

期刊

FEBS LETTERS
卷 582, 期 17, 页码 2595-2600

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.febslet.2008.06.036

关键词

P-glycoprotein; breast cancer resistance protein; PSC833; verapamil; c-Jun; c-Jun NH2-terminal kinase

向作者/读者索取更多资源

This study investigated whether P-glycoprotein ( Pgp) and breast cancer resistance protein ( BCRP) are linked in terms of expression. RT- PCR and Western blot analyses showed that the lung cancer cell line SK- MES- 1/ WT expressed BCRP. In a drug- free state, BCRP expression was signi. cantly down- regulated in doxorubicin- resistant SK- MES- 1/ DX1000 cells overexpressing Pgp. Pharmacological inhibitors ( PSC833 or verapamil) or siRNA for Pgp inhibited the down- regulation of BCRP, which was con. rmed by confocal microscopy. PSC833 induced the phosphorylation of c- Jun NH2- terminal kinase ( JNK) and c- Jun, while the JNK inhibitor SP600125 inhibited this e. ect. Dominant negative c- Jun decreased the expression of BCRP, but increased that of Pgp. These results indicate that Pgp down- regulates BCRP expression in a drug- free state in which JNK/ c- Jun is involved. (c) 2008 Federation of European Biochemical Societies. Published by Elsevier B. V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据